Literature DB >> 14611742

New treatments for diabetic neuropathic foot ulceration: views from a wound healing unit.

Dean T Williams1, Keith G Harding.   

Abstract

The management of diabetic foot ulceration remains problematic despite advances in treatments. The evidence for many treatments is lacking and clinical experience remains important. Current diabetic foot ulcer management and an evaluation of new therapies are discussed. Research in wound healing and diabetic foot disease can complement each other in accurately evaluating and treating diabetic foot ulceration. This would aid in formulating personalized therapies, tailoring treatments to optimize the ulcer healing environment.

Entities:  

Mesh:

Year:  2003        PMID: 14611742     DOI: 10.1007/s11892-003-0009-x

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   5.430


  32 in total

1.  Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus.

Authors:  D G Armstrong; L A Lavery; M Sariaya; H Ashry
Journal:  J Foot Ankle Surg       Date:  1996 Jul-Aug       Impact factor: 1.286

2.  Diabetic neuropathic foot ulcer: successful treatment by low-intensity laser therapy.

Authors:  A Schindl; M Schindl; H Pernerstorfer-Schön; K Kerschan; R Knobler; L Schindl
Journal:  Dermatology       Date:  1999       Impact factor: 5.366

3.  Conservative management of osteomyelitis in the feet of diabetic patients.

Authors:  P Venkatesan; S Lawn; R M Macfarlane; E M Fletcher; R G Finch; W J Jeffcoate
Journal:  Diabet Med       Date:  1997-06       Impact factor: 4.359

4.  Angiogenesis in necrotic ulcers treated with hyperbaric oxygen.

Authors:  M C Heng; J Harker; G Csathy; C Marshall; J Brazier; S Sumampong; E Paterno Gomez
Journal:  Ostomy Wound Manage       Date:  2000-09       Impact factor: 2.629

5.  Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy.

Authors:  J M Embil; K Papp; G Sibbald; J Tousignant; J M Smiell; B Wong; C Y Lau
Journal:  Wound Repair Regen       Date:  2000 May-Jun       Impact factor: 3.617

6.  Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment.

Authors:  J B Wright; K Lam; R E Burrell
Journal:  Am J Infect Control       Date:  1998-12       Impact factor: 2.918

Review 7.  Infections and diabetes: mechanisms and prospects for prevention.

Authors:  P Pozzilli; R D Leslie
Journal:  Diabet Med       Date:  1994-12       Impact factor: 4.359

Review 8.  Preventing foot ulceration and amputation by decompressing peripheral nerves in patients with diabetic neuropathy.

Authors:  A Lee Dellon
Journal:  Ostomy Wound Manage       Date:  2002-09       Impact factor: 2.629

9.  Applied felted foam for plantar pressure relief is an efficient therapy in neuropathic diabetic foot ulcers.

Authors:  S Zimny; M F Meyer; H Schatz; M Pfohl
Journal:  Exp Clin Endocrinol Diabetes       Date:  2002-10       Impact factor: 2.949

10.  Experience with the vacuum assisted closure negative pressure technique in the treatment of non-healing diabetic and dysvascular wounds.

Authors:  Michael P Clare; Timothy C Fitzgibbons; Scott T McMullen; R Colleen Stice; Dennis F Hayes; Loree Henkel
Journal:  Foot Ankle Int       Date:  2002-10       Impact factor: 2.827

View more
  2 in total

Review 1.  Reactive oxygen species and bacterial biofilms in diabetic wound healing.

Authors:  Aksone Nouvong; Aaron M Ambrus; Ellen R Zhang; Lucas Hultman; Hilary A Coller
Journal:  Physiol Genomics       Date:  2016-10-07       Impact factor: 3.107

Review 2.  Platelet-rich plasma: support for its use in wound healing.

Authors:  Kathleen M Lacci; Alan Dardik
Journal:  Yale J Biol Med       Date:  2010-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.